Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan, Journal of Oncology Pharmacy Practice, vol.14, issue.1, pp.29-38, 2011. ,
DOI : 10.1007/s00420-007-0284-y
Surface contamination of antineoplastic drug vials: Comparison of unprotected and protected vials, American Journal of Health-System Pharmacy, vol.67, issue.6, pp.428-429, 2010. ,
DOI : 10.2146/ajhp080621
Environmental Contamination with Hazardous Drugs in Quebec Hospitals, The Canadian Journal of Hospital Pharmacy, vol.65, issue.6, pp.428-435, 2012. ,
DOI : 10.4212/cjhp.v65i6.1190
Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals, International Archives of Occupational and Environmental Health, vol.8, issue.1, pp.307-313, 2013. ,
DOI : 10.1080/15459624.2011.537510
Multicenter Study of Environmental Contamination with Antineoplastic Drugs in 36 Canadian Hospitals: A 2013 Follow-up Study, Journal of Occupational and Environmental Hygiene, vol.59, issue.3, pp.87-94, 2015. ,
DOI : 10.1093/annhyg/mes061
Environmental Contamination with Cyclophosphamide, Ifosfamide, and Methotrexate: A Study of 51 Canadian Centres, The Canadian Journal of Hospital Pharmacy, vol.68, issue.4, pp.279-289, 2015. ,
DOI : 10.4212/cjhp.v68i4.1467
Disponible en ligne sur : https, 2016. ,
Part III: Drug monographs Cancer chemotherapy handbook, Selon Micromedex. [consulté le 06.07.2016]. xlv Product Information. Cytoxan®, cyclophosphamide, pp.129-975, 1994. ,
Pharmacokinetics of divided-dose ifosfamide, Clinical Pharmacology & Therapeutics, vol.19, issue.3, pp.365-370, 1976. ,
DOI : 10.1002/cpt1976193365
Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings, 2004. ,
Acute symptoms associated with antineoplastic drug handling among nurses, Cancer Nursing, vol.16, issue.4, pp.288-295, 1993. ,
DOI : 10.1097/00002820-199308000-00005
Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature, Journal of Oncology Pharmacy Practice, vol.8, issue.2, pp.69-78, 2005. ,
DOI : 10.1111/j.0272-4332.2004.00433.x
Reproductive Health Risks Associated With Occupational Exposures to Antineoplastic Drugs in Health Care Settings, Journal of Occupational and Environmental Medicine, vol.56, issue.9, pp.901-910, 2014. ,
DOI : 10.1097/JOM.0000000000000249
Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists, Journal of Applied Toxicology, vol.48, issue.3, pp.196-201, 2013. ,
DOI : 10.1539/joh.48.517
Environmental contamination with hazardous drugs in Quebec hospitals, Can J Hosp Pharm, vol.65, pp.428-435, 2012. ,
Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals, International Archives of Occupational and Environmental Health, vol.8, issue.1, pp.307-313, 2013. ,
DOI : 10.1080/15459624.2011.537510
Multicenter Study of Environmental Contamination with Antineoplastic Drugs in 36 Canadian Hospitals: A 2013 Follow-up Study, Journal of Occupational and Environmental Hygiene, vol.59, issue.3, pp.87-94, 2015. ,
DOI : 10.1093/annhyg/mes061
Environmental Contamination with Cyclophosphamide, Ifosfamide, and Methotrexate: A Study of 51 Canadian Centres, The Canadian Journal of Hospital Pharmacy, vol.68, issue.4, pp.279-289, 2015. ,
DOI : 10.4212/cjhp.v68i4.1467
Part III: Drug monographs, Cancer chemotherapy handbook, pp.129-975, 1994. ,
Pharmacokinetics of divided-dose ifosfamide, Clinical Pharmacology & Therapeutics, vol.19, issue.3, pp.365-370, 1976. ,
DOI : 10.1002/cpt1976193365
Clinical Pharmacology of 5-Fluorouracil, Clinical Pharmacokinetics, vol.16, issue.4, pp.215-237, 1989. ,
DOI : 10.2165/00003088-198916040-00002
Biological monitoring of occupational exposure to 5-fluorouracil: Urinary ??-fluoro-??-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel, Journal of Chromatography B, vol.878, issue.27, pp.2630-2634, 2010. ,
DOI : 10.1016/j.jchromb.2010.02.011
Evaluation of Environmental Contaminations and Occupational Exposures Involved in Preparation of Chemotherapeutic Drugs, YAKUGAKU ZASSHI, vol.130, issue.6, pp.903-910, 2010. ,
DOI : 10.1248/yakushi.130.903
Occupational exposure to antineoplastic drugs in four Italian health care settings, Toxicology Letters, vol.213, issue.1, pp.107-115, 2012. ,
DOI : 10.1016/j.toxlet.2011.03.028
Antineoplastic drug contamination in the urine of Canadian healthcare workers, International Archives of Occupational and Environmental Health, vol.26, issue.3, pp.933-941, 2015. ,
DOI : 10.1093/mutage/geq102
Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake, Revista Panamericana de Salud P??blica, vol.32, issue.4, pp.307-315, 2012. ,
DOI : 10.1590/S1020-49892012001000010
Spot Urine Estimations Are Equivalent to 24-Hour Urine Assessments of Urine Protein Excretion for Predicting Clinical Outcomes, International Journal of Nephrology, vol.3, issue.2, supplement 1, p.156484, 2015. ,
DOI : 10.1053/j.ajkd.2014.01.002
Validity of spot urine samples as a surrogate measure of 24-hour porphyrin excretion rates. Evaluation of diurnal variations in porphyrin, mercury, and creatinine concentrations among subjects with very low occupational mercury exposure, J Occup Environ Med, vol.40, pp.1090-1101, 1998. ,
Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings, Med Lav, vol.103, pp.394-401, 2012. ,
Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital, Ann Occup Hyg, vol.57, pp.251-260, 2013. ,